These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5113310)

  • 21. Guidelines for management of malignant melanoma of the lower limb--based on a study of long-term behaviour.
    Lewis MH; Hill JT; Leopold JG; Hughes LE
    Clin Oncol; 1982 Dec; 8(4):341-9. PubMed ID: 7168927
    [No Abstract]   [Full Text] [Related]  

  • 22. Ring chromosome 7, hyperpigmented skin lesions and malignant melanoma.
    DeLozier-Blanchet CD; Masouyé I; Vollenweider S
    Am J Med Genet; 1992 Aug; 43(6):1039-40. PubMed ID: 1415332
    [No Abstract]   [Full Text] [Related]  

  • 23. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness.
    Bahuau M; Vidaud D; Kujas M; Palangié A; Assouline B; Chaignaud-Lebreton M; Prieur M; Vidaud M; Harpey JP; Lafourcade J; Caille B
    Ann Genet; 1997; 40(2):78-91. PubMed ID: 9259954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
    Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
    Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the treatment of skin melanoma].
    Volodina GI; Abdullin AS
    Vopr Onkol; 1966; 12(1):84-6. PubMed ID: 5973081
    [No Abstract]   [Full Text] [Related]  

  • 27. Papillon-Lefèvre syndrome and malignant melanoma.
    Cook GP
    Dermatology; 2009; 219(2):187-8. PubMed ID: 19506350
    [No Abstract]   [Full Text] [Related]  

  • 28. [Spontaneous regression of malignant melanoma with regional glandular metastasis].
    Mac Clure E; de Lacerda PR; Fernandes Filho C
    Hospital (Rio J); 1967 May; 71(5):1295-9. PubMed ID: 5303461
    [No Abstract]   [Full Text] [Related]  

  • 29. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
    Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
    Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular staging of melanoma.
    Shivers S; Alsarraj M; Guiliano R; Jakub J; Pendas S; Reintgen D
    Ann Surg Oncol; 2004 Nov; 11(11):953-4. PubMed ID: 15525822
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal risk factors for cutaneous malignant melanoma: follow-up of 2,594,783 Danes born from 1950 to 2002.
    Olesen AV; Parner ET; Mortensen PB; Sørensen HT; Olsen J
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):155-61. PubMed ID: 19124493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
    Kammula US; Ghossein R; Bhattacharya S; Coit DG
    J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization.
    Speicher MR; Prescher G; du Manoir S; Jauch A; Horsthemke B; Bornfeld N; Becher R; Cremer T
    Cancer Res; 1994 Jul; 54(14):3817-23. PubMed ID: 8033101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.
    Herbst RA; Larson A; Weiss J; Cavenee WK; Hampton GM; Arden KC
    Cancer Res; 1995 Jun; 55(12):2494-6. PubMed ID: 7780954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis.
    Bastian BC
    Pathology; 2004 Oct; 36(5):458-61. PubMed ID: 15370116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.
    Kurul S; Taş F; Büyükbabani N; Mudun A; Baykal C; Camlica H
    Jpn J Clin Oncol; 2005 Apr; 35(4):202-6. PubMed ID: 15845569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.